AzTrials
AzTrials

LaparotomyNCT03966768

DuraMesh Laparotomy Study

A study testing Duramesh suturable mesh for laparotomy closure and Conventional suture for laparotomy closure in people with Laparotomy and Suture; Complications, Mechanical, run by Mesh Suture Inc..

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. Read more about this study

Who is it for?
Ages 18 to 75 years
What is being tested?
Duramesh suturable mesh for laparotomy closure and Conventional suture for laparotomy closure
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
15 Oct 2023to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Midline laparotomy greater than 5 cm in length
  • Urgent or emergent surgery following trauma
  • Urgent or emergent surgery for diverticulitis
  • Large or small bowel obstruction, acute abdomen, or intra-abdominal hemorrhage.
  • Open abdomen after midline laparotomy.

Who cannot join

  • Prior hernia repair or existing abdominal mesh
  • Metastatic cancer
  • Pregnancy
  • Immunosuppression.

About this study

Official title: DuraMesh Laparotomy Closure Following Trauma and Emergency Surgery

This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. One hundred (100) patients will be randomized (2:1) to Duramesh laparotomy closure versus conventional suture closure.

After the patient has been confirmed to be a candidate for the trial, randomization will be performed in the operating room upon completion of the index abdominal procedure. Duramesh will be provided for patients assigned to the Duramesh treatment arm. Patients will be followed for 1 year following laparotomy closure at follow-up intervals of 1 month, 3 months, 6 months, and 12 months.

Read the detailed description

Primary Laparotomy Closure Treatment 1) Study Group - Duramesh Laparotomy Closure (DLC) Treatment 2) Control Group - Conventional Suture Closure (CSC)

Patients undergoing a midline laparotomy for trauma or emergency surgery will have their abdominal wall laparotomy incision closed with size 0 Duramesh suturable mesh. Patients randomized to conventional laparotomy closure will be closed using size

1 slowly-absorbing (PDS) single strand or looped suture, based on surgeon preference.

While it would be preferable to identify a single conventional suture to serve as the control group, polling of potential participating surgeons demonstrated a preference for both single strand and looped sutures to be available for use in the conventional suture closure group. Both Duramesh and conventional sutures will be placed using a standardized closure technique that incorporates 1cm wide bites and 1cm spacing, as this is the established technique for trauma and emergency laparotomy closure at both participating institutions. An effort to quantify suture to wound length ratio will be made in an effort to confirm standardization of closure technique between groups. The small-bites surgical closure technique popular in Europe has not been adopted by trauma and emergency surgeons at either institution given concerns related to early dehiscence and the inability to extrapolate the STITCH trial data to a US trauma population. The surgeons at both institutions do not believe it acceptable to generalize the European trial with a mean BMI of 24 to the United States population, nor do they believe it wise to close the abdominal wall with a 2-0 polydioxanone suture, as this technique trended towards a higher rate of acute fascial dehiscence (burst abdomen).

All patients will be assessed for post-operative complications ( i . e . , infection, seroma, hematoma), a t 1 , 3 , 6 , and 12 months p o s t o p e r a t i v e l y . Patient will also be assessed for incisional hernia formation at the same post-operative time points (1, 3, 6, 12 months). Hernia outcomes will be based on physical examination, with ultrasound used for any uncertainties. While surveillance imaging has been shown to be more sensitive for hernia detection, the primary purpose of this study is to compare the safety profile of Duramesh laparotomy closure to standard closure technique. Surveillance imaging for hernia identification is not a part of standard clinical practice at the participating study sites. The rate of clinically relevant hernias found on physical exam will be used to inform future efficacy studies, where routine surveillance imaging will be incorporated into the study design.

In addition to the patients undergoing primary laparotomy closure following an open trauma or emergency abdominal surgery, an additional subset of 20 patients undergoing delayed primary closure of an open abdomen will also be studied. These patients represent a particularly challenging clinical problem, for which there is no standard approach to repair. All 20 study patients undergoing delayed primary closure of an open abdomen will be closed with #1 or #2 Duramesh and followed according to the same post-operative protocol as those undergoing primary laparotomy closure. This subgroup is too small for randomization to provide useful data for comparison, and thus will be used to provide only a descriptive analysis of this early experience with delayed Duramesh closure of the open abdomen. The safety of Duramesh closure in this patient population can be extrapolated from the previously referenced experience of mesh strip closures in contaminated incisional hernias.

Being tested
Duramesh suturable mesh for laparotomy closure, Conventional suture for laparotomy closure
Medical subject headings
Incisional Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Duramesh suturable mesh for laparotomy closureDevice

    Patients undergoing laparotomy will be closed with Duramesh suturable mesh

  • Conventional suture for laparotomy closureDevice

    Patients undergoing laparotomy will be closed with conventional polydiaxonone suture

Study groups in NCT03966768
Study groupRoleWhat they receive
Duramesh suturable mesh for laparotomy closureExperimentalPatients undergoing a midline laparotomy for trauma or emergency surgery will be closed with Duramesh suturable mesh.
Receives: Device: Duramesh suturable mesh for laparotomy closure
Conventional suture closure for laparotomy closureExperimentalPatients randomized to conventional laparotomy closure will be closed using size 1 slowly-absorbing polydiaxonone (PDS) single strand or looped suture, based on surgeon preference.
Receives: Device: Conventional suture for laparotomy closure
Open abdomen group closed in delayed fashion with DurameshExperimentalPatients undergoing delayed primary closure of an open abdomen will also be studied. 20 study patients undergoing delayed primary closure of an open abdomen will be closed with Number 1 or Number 2 Duramesh
Receives: Device: Duramesh suturable mesh for laparotomy closure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Surgical site infection

    Superficial or deep infection of the surgical site

    Measured: 1 month

  2. Surgical site infection

    Superficial or deep infection of the surgical site

    Measured: 3 months

  3. Surgical site infection

    Superficial or deep infection of the surgical site

    Measured: 6 months

  4. Surgical site infection

    Superficial or deep infection of the surgical site

    Measured: 12 months

Secondary outcomes (16)
  1. Surgical site occurrence

    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality

    Measured: 1 month

  2. Surgical site occurrence

    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality

    Measured: 3 months

  3. Surgical site occurrence

    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality

    Measured: 6 months

  4. Surgical site occurrence

    Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality

    Measured: 12 months

  5. Intraoperative and hospitalization endpoints

    Details regarding abdominal wall closure

    Measured: Within 30 days

  6. Intraoperative and hospitalization endpoints

    Length of hospital stay

    Measured: Within 30 days

  7. Intraoperative and hospitalization endpoints

    Length of the laparotomy incision and length of suture remnant

    Measured: Within 30 days

  8. Intraoperative and hospitalization endpoints

    Size of Duramesh used

    Measured: Within 30 days

  9. Hernia formation

    Clinical development of an incisional hernia

    Measured: anytime within 12 months

  10. Patient reported outcomes

    NRS pain scale

    Measured: 3 months

  11. Patient reported outcomes

    NRS pain scale

    Measured: 6 months

  12. Patient reported outcomes

    HerQles

    Measured: 6 months

  13. Patient reported outcomes

    SF-36

    Measured: 6 months

  14. Patient reported outcomes

    HerQles

    Measured: 12 months

  15. Patient reported outcomes

    SF-36

    Measured: 12 months

  16. Patient reported outcomes

    NRS pain scale

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2019
  2. Study start15 Oct 2023 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Why it stopped: Mutual decision Walter Reed/U Maryland and Mesh Suture Inc.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Clinical Trial
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03966768
Sponsor's protocol ID
0001
Status last verified
Sep 2022
First submitted
23 May 2019
Last updated
13 Sep 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: As per the sponsor wishes

Publications

  • Dumanian GA, Lanier ST, Souza JM, Young MW, Mlodinow AS, Boller AM, Mueller KH, Halverson AL, McGee MF, Stulberg JJ. Mesh sutured repairs of contaminated incisional hernias. Am J Surg. 2018 Aug;216(2):267-273. doi: 10.1016/j.amjsurg.2017.10.025. Epub 2017 Oct 25.

    PubMed 29108644
  • Lanier ST, Dumanian GA, Jordan SW, Miller KR, Ali NA, Stock SR. Mesh Sutured Repairs of Abdominal Wall Defects. Plast Reconstr Surg Glob Open. 2016 Sep 28;4(9):e1060. doi: 10.1097/GOX.0000000000001060. eCollection 2016 Sep.

    PubMed 27757361
  • Dumanian GA, Tulaimat A, Dumanian ZP. Experimental study of the characteristics of a novel mesh suture. Br J Surg. 2015 Sep;102(10):1285-92. doi: 10.1002/bjs.9853. Epub 2015 Jul 8.

    PubMed 26154703
  • Souza JM, Dumanian ZP, Gurjala AN, Dumanian GA. In vivo evaluation of a novel mesh suture design for abdominal wall closure. Plast Reconstr Surg. 2015 Feb;135(2):322e-330e. doi: 10.1097/PRS.0000000000000910.

    PubMed 25626817

Questions about this trial

What is this clinical trial studying?

A study testing Duramesh suturable mesh for laparotomy closure and Conventional suture for laparotomy closure in people with Laparotomy and Suture; Complications, Mechanical, run by Mesh Suture Inc..

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 13 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Surgical site infection (time frame: 1 month). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03966768, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in